129 related articles for article (PubMed ID: 8338951)
21. Usefulness of classic cytogenetic testing compared to fluorescence in situ hybridization in genetic diagnosis of 58 patients with myelodysplastic syndromes.
Skonieczka K; Duszeńko E; Wyrowińska E; Haus O
Pol Arch Med Wewn; 2009 Jun; 119(6):366-72. PubMed ID: 19694218
[TBL] [Abstract][Full Text] [Related]
22. Structural aberrations of chromosome 7 revealed by a combination of molecular cytogenetic techniques in myeloid malignancies.
Brezinová J; Zemanová Z; Ransdorfová S; Pavlistová L; Babická L; Housková L; Melichercíková J; Sisková M; Cermák J; Michalová K
Cancer Genet Cytogenet; 2007 Feb; 173(1):10-6. PubMed ID: 17284364
[TBL] [Abstract][Full Text] [Related]
23. Classical morphology, esterase cytochemistry, and interphase cytogenetics of peripheral blood and bone marrow smears.
Jacobsson B; Bernell P; Arvidsson I; Hast R
J Histochem Cytochem; 1996 Nov; 44(11):1303-9. PubMed ID: 8918905
[TBL] [Abstract][Full Text] [Related]
24. Cytogenetics and fluorescence in-situ hybridization in detection of hematological malignancies.
Frenny VJ; Antonella Z; Luisa A; Shah AD; Sheth JJ; Rocchi M
Indian J Cancer; 2003; 40(4):135-9. PubMed ID: 14716109
[TBL] [Abstract][Full Text] [Related]
25. Clonal origin and evolution of myelodysplastic syndrome analyzed by dysplastic morphology and fluorescence in situ hybridization.
Fu CM; Chen ZX; Liu DD; Zhang J; Pan JL; Liang JY
Int J Hematol; 2015 Jan; 101(1):58-66. PubMed ID: 25430081
[TBL] [Abstract][Full Text] [Related]
26. Dual colour FISH in paraffin wax embedded bone trephines for identification of numerical and structural chromosomal abnormalities in acute myeloid leukaemia and myelodysplasia.
Le Maitre CL; Byers RJ; Liu Yin JA; Hoyland JA; Freemont AJ
J Clin Pathol; 2001 Sep; 54(9):730-3. PubMed ID: 11533086
[TBL] [Abstract][Full Text] [Related]
27. Clonality analysis of hematopoietic cell lineages in acute myeloid leukemia and translocation (8;21): only myeloid cells are part of the malignant clone.
van Lom K; Hagemeijer A; Vandekerckhove F; de Greef GE; Sacchi N; Löwenberg B
Leukemia; 1997 Feb; 11(2):202-5. PubMed ID: 9009081
[TBL] [Abstract][Full Text] [Related]
28. [Pattern analytic investigations of blast cells in myelodysplastic syndrome and secondary acute myeloid leukemia].
Baumann I; Harms H; Kuse R; Feller AC; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1990; 74():135-8. PubMed ID: 1708571
[TBL] [Abstract][Full Text] [Related]
29. Limited utility of fluorescence in situ hybridization for common abnormalities of myelodysplastic syndrome at first presentation and follow-up of myeloid neoplasms.
Seegmiller AC; Wasserman A; Kim AS; Kressin MK; Marx ER; Zutter MM; Mosse CA
Leuk Lymphoma; 2014 Mar; 55(3):601-5. PubMed ID: 23876099
[TBL] [Abstract][Full Text] [Related]
30. Multilineage involvement in the 5q- syndrome: a fluorescent in situ hybridization study on bone marrow smears.
Bigoni R; Cuneo A; Milani R; Cavazzini F; Bardi A; Roberti MG; Agostini P; della Porta M; Specchia G; Rigolin GM; Castoldi G
Haematologica; 2001 Apr; 86(4):375-81. PubMed ID: 11325642
[TBL] [Abstract][Full Text] [Related]
31. Clonal analysis of myelodysplastic syndrome: monosomy 7 is expressed in the myeloid lineage, but not in the lymphoid lineage as detected by fluorescent in situ hybridization.
Gerritsen WR; Donohue J; Bauman J; Jhanwar SC; Kernan NA; Castro-Malaspina H; O'Reilly RJ; Bourhis JH
Blood; 1992 Jul; 80(1):217-24. PubMed ID: 1611087
[TBL] [Abstract][Full Text] [Related]
32. Analysis of hematologic diseases using conventional karyotyping, fluorescence in situ hybridization (FISH), and comparative genomic hybridization (CGH).
Wilkens L; Tchinda J; Burkhardt D; Nolte M; Werner M; Georgii A
Hum Pathol; 1998 Aug; 29(8):833-9. PubMed ID: 9712425
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the utility of peripheral blood vs bone marrow in karyotype and fluorescence in situ hybridization for myelodysplastic syndrome diagnosis.
Asadi Fakhr Z; Mehrzad V; Izaditabar A; Salehi M
J Clin Lab Anal; 2018 Nov; 32(9):e22586. PubMed ID: 29893006
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of cytogenetics in leukemias.
VinSheth FJ; Sheth JJ; Patel AI; Shah AD; Verhest A
Indian J Cancer; 2002; 39(4):139-42. PubMed ID: 12928572
[TBL] [Abstract][Full Text] [Related]
35. Cytogenetic characterization of acute myeloid leukemia in Shwachman's syndrome. A case report.
Spirito FR; Crescenzi B; Matteucci C; Martelli MF; Mecucci C
Haematologica; 2000 Nov; 85(11):1207-10. PubMed ID: 11064470
[TBL] [Abstract][Full Text] [Related]
36. rHuEpo administration in patients with low-risk myelodysplastic syndromes: evaluation of erythroid precursors' response by fluorescence in situ hybridization on May-Grunwald-Giemsa-stained bone marrow samples.
Rigolin GM; Porta MD; Bigoni R; Cavazzini F; Ciccone M; Bardi A; Cuneo A; Castoldi G
Br J Haematol; 2002 Dec; 119(3):652-9. PubMed ID: 12437640
[TBL] [Abstract][Full Text] [Related]
37. Interphase cytogenetic analysis of in vivo differentiation in the myelodysplasia of Down syndrome.
Zipursky A; Wang H; Brown EJ; Squire J
Blood; 1994 Oct; 84(7):2278-82. PubMed ID: 7919346
[TBL] [Abstract][Full Text] [Related]
38. Progression of a myelodysplastic syndrome to pre-B acute lymphoblastic leukemia: a case report and cell lineage study.
Abruzzese E; Buss D; Rainer R; Pettenati MJ; Rao PN
Ann Hematol; 1996 Jul; 73(1):35-8. PubMed ID: 8695722
[TBL] [Abstract][Full Text] [Related]
39. Use of fluorescence in situ hybridization for retrospective detection of aneuploidy in multiple myeloma.
Lee W; Han K; Drut RM; Harris CP; Meisner LF
Genes Chromosomes Cancer; 1993 Jul; 7(3):137-43. PubMed ID: 7687866
[TBL] [Abstract][Full Text] [Related]
40. Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations.
Lai JL; Preudhomme C; Zandecki M; Flactif M; Vanrumbeke M; Lepelley P; Wattel E; Fenaux P
Leukemia; 1995 Mar; 9(3):370-81. PubMed ID: 7885035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
